NCT02989493View on ClinicalTrials.gov

Testing Doxazosin to Treat Stress Mechanisms in Alcoholism

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Alcoholism
Interventions
DRUG

Doxazosin

Doxazosin

OTHER

Placebo

Placebo

Trial Locations (1)

53706

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT02989493 - Testing Doxazosin to Treat Stress Mechanisms in Alcoholism | Biotech Hunter | Biotech Hunter